Rising fentanyl-related overdose deaths in British Columbia

Canadian Journal of Addiction

Volumn 6, Issue 1, 2015, Pages 4-6

  Jafari, Siavash ^a   Buxton, Jane A ^a,b   Joe, Ronald ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; FENTANYL; NALOXONE; OXYCODONE;

ARTICLE; BRITISH COLUMBIA; CLINICAL FEATURE; DRUG EFFECT; DRUG FATALITY; DRUG OVERDOSE; EMERGENCY; HARM REDUCTION; HUMAN; SYMPTOM;

EID: 84947487414     PISSN: 23684720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. MMWR Morb Mortal Wkly Rep. 2012 Feb 17;61(6):101-5. Community-based opioid overdose prevention programs providing naloxone-United States, 2010. Centers for Disease Control and Prevention (CDC)
2. BCCDC BC Drug Use Epidemiology. CHAPTER 2: Substance use trends. 2014. Accessed January 15th 2015 at: http://www. bccdc.ca/prevention/HarmReduction/BCDrugUseEpid/ default.htm
3. RCMP (Royal Canadian Mounted Police). Significant counterfeit drug seizure prompts warning. 2014. Accessed January 2015 at: http://bc.cb.rcmp-grc.gc.ca/ViewPage.action?siteNo deId=50&languageId=1&contentId=38566
4. Schumann H, Erickson TTM, Zautcke JL, and Denton JS. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clinical Toxicology 2008 46, 501-506
5. Algren DA, Monteilh C.P., Mohan P, Schier J.G., Martin B, Hepler B.R., et al. Fentanylassociated Fatalities Among Illicit Drug Users in Wayne County, Michigan (July 2005-May 2006). J. Med. Toxicol. 2013 9:106-115
6. CDSA. Controlled Drug and Substance Act. Ministry of Justice Canada. 1996. Accessed January 2015 at: http://lawslois. justice.gc.ca/PDF/C-38.8.pdf
7. CSA. Title 21 United States Code Controlled Substance Act 2012 Access January 2015 at: http://www.deadiversion.usdoj. gov/21cfr/21usc/index.html
8. Paix A, Coleman A, Lees J. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain 1995;63:263e269
9. CCENDU Drug Alert 2014. Increasing Availability of Counterfeit Oxycodone Tablets Containing Fentanyl. Accessed December 4th 2014 at: http://www.ccsa.ca/Resource%20Library/CCSACCENDU-Oxycontin-Fentanyl-Alert-2014-en.pdf
10. Fletcher T. Bad heroin linked to rash of overdoses confirmed as straight fentanyl. 2014. MetroNews. Accessed January 2015 at: http://metronews.ca/news/vancouver/1184652/badheroin-linked-to-rash-of-overdoses-confirmed-as-straightfentanyl/
11. Hess R G Stiebler and Herz A. Pharmacokinetics of fentanyl in man and the rabbit Europ J Clin Pharma. 1972. 4:137-141
12. Bateman DN. Opioids. Medicine 2011;40(3):141-143
13. Lyttle MD, Verma S, Isaac R. Transdermal Fentanyl in Deliberate Overdose in Pediatrics. Pediatr Emerg Care. 2012 May;28(5):463-4
14. Burnham TH, ed. Drug Facts and Comparisons. St. Louis: Facts and Comparisons, Inc. 2002: 382
15. BMJ best practice. Opioid overdose. 2014. Accessed February 2015 at: http://bestpractice.bmj.com/best-practice/monograph/ 339/treatment/step-by-step.html
16. Berge KH, Dillon KR, Sikkink KM, Taylor TK, and Lanier WL. Diversion of Drugs Within Health Care Facilities, a Multiple-Victim Crime: Patterns of Diversion, Scope, Consequences, Detection, and Prevention. Mayo Clin Proc. 2012;87(7):674-682
17. Joranson DE, Gilson AM. Drug crime is a source of abused pain medications in the United States. J Pain Symptom Manage. 2005;30(4):299-301
18. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005 Nov-Dec;6(6):432-42
19. Banjo O, Tzemis D, Al-Qutub D, Amlani A, Kesselring A, Buxton JA. A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. CMAJ Open 2014.DOI:10.9778/cmajo.20140008